Hand sanitizer and surface cleaner company Byotrol had a strong 2020 and are confident about 2021 Watch Now
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East and have access to Premium Chat. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
“you do talk utter crap and you're not very funny either”
Oh dear Ophidian, unfortunately you probably won’t see my post amongst the noise here but hey ho!
I sold my majority trading pot here at 196 from memory, then a few thereafter. Went long on bitcoin, from $9.2 which I posted on some of my gold BB’s in advance!
Now I’ve closed down some other position I fancied some more AVCT, well timing is everything, but you of all people understand trading!
Ps check out GRL!
Agreed. I'm too far in to buy more (because of the impact of increasing price takes it over 50%) - despite wanting too. My top was £1.87 although lowest was 16p. The wait for the box to open cannot be much longer. Whatever happens its been a ride.
you do talk utter crap and you're not very funny either
Was waiting for 121, didn’t come so bought today at 129 and a bit. Clock is ticking down now. So good time to add to the trading pot especially after closing my BTC long! RNS tomorrow, nah that would be sick! I mean how could you explain that! Well not long to wait now! Atb longs
Mortality not morality.
Not quite a silverback... https://66.media.tumblr.com/73d80023a3fff00022fc1f74d3bd5e30/tumblr_n1k1mo5AWB1qf47bgo1_1280.jpg
The Silverbacks have been beating their chests in full challenge mode today. It has made for great reading and I go away from the bb today with a little more Knowledge than I arrived with.
I think the Silverback who gets full rutting rights imo (I'm not a zoologist and certainly not a doctor) is Ophidian. Good debate today gentlemen. Keep it up.
Oh dear oh dear - where to begin: You butted into a conversation which was precisely about the timeframe for completing the clinical validation. One in which I had used the most recent available data to establish a likely recruitment rate into Falcon (CONDOR), trying to be clever you then said
"The 20 patients Orphidian mentions though would be scattered across the different hospitals in the UK so not as easy as implied - I suspect they will want to reduce the number of centers testing for consistency."
thereby demonstrating that you have zero understanding of what is involved in a clinical validation.
I have long suspected you have some peripheral involvement in the industry too many times you get it nearly right but not actually right betraying your lack of genuine experience and understanding.
We have another classic example here "Well that's what I did in the seven clinical trials I ran" - I'd bet serious money you have never run a clinical trial. You may well have had accountability or input at some level to an in use testing assessment but that is not a clinical trial and it certainly is not (in itself) a clinical validation although it may well form a very tiny part of the overall validation.
Why persist with your stupid vendetta, your rudeness and your childish spelling. Have some self respect and stop trying to make out you know things you clearly don't.
All that said a deal is a deal and I will publish the Timeline under a separate topic.
p.s. a part of the validation specifically targets different use environments hence your statement " I suspect they will want to reduce the number of centers testing for consistency" is nonsense and is what betrayed you this time amongst other things.
Whoop whoop. Only another 127 to go and I make top 10.
I saw the stuff on the other tests and thought that will upset some. The unmet need at moment is for a test that doesn't need a machine and doesn't need trained personnel I.e. a self test.
I don't give a toss about any competitor that isn't that. If Avacta don't deliver that then the cat is dead. Until we open the box though we just don't know and pontificating from high up on a donkey doesn't help. I am gutted my shares are worth less today than Friday but wasn't long ago £1.30 was a target.
Jimmy I’d go to KFC and get a family bucket and then lay on a shezlong like Henry the VIII smashing the lot. But I can’t disagree about the draw of some good chicken.
How very dare you speak on my behalf...! but yeah, you’re right. I’ve done my research, I’m confident and I’m certainly not wetting my bed over a couple of low throughput competitors no matter how much of a (political) game changer they’re declared to be.
Sensible stuff RD. In my ranking of favourite posters, you’ve just moved above Gazala.
Wyn has a point. Share price movements can happen quickly particularly in companies as leaky as Avacta and before the majority of PIs know why - the placing is an example - indeed someone named the exact price before the RNS.
However, at the moment £1.30 seems to be the balance point and it moves around this. PL75 is only making the point that it is the nature of the beast for it to do that but we should treat them both the same. If you have done your own research, spread your scanning beyond Avacta and take proven pump and dumpers with a pinch of salt then risks and emotions should be lower.
We are back to the RNS will sort this out one way or the other. If other companies don't mention LFD I'm not worrying
An afternoon RNS to shake things up, preferably whilst I'm on the way to Nandos so I can upgrade to a whole chicken
If being civil is spraying utter sh.t everywhere, then I’d better leave you to your washing...
I’ll wet my pants if there is an RNS tomorrow :)
If that happened I’d probably assume a company I’ve never heard of, as I’ve done no research, has released an inferior test and I’d have wet the bed.
For someone declaring their decades of trading experience I’m wondering why you’re wetting the bed over a 10% price movement? Were you uncontrollably elated when it moved up 10% recently?
ok PL I have tried to be civil but you can just F*ck right off now
Sorry ophidian to carry on but you say that the SP between major news is irrelevant. That is on the (imo dangerous) assumption that you know as much as everyone else. In other words Share prices can move before news is formally announced. Then all of a sudden the chart is warning whats going to happen, So, for example not because I think this will happen but because I think you don't, what would you do if at 4:00pm on Friday the sp fell sharply from 132p to 118p? in say, 5 minutes? No RSN, no news you can find. What then?
Well given I haven't mentioned clinical validity it seems odd you have gone down that route. You suggested that there were 20 patients per day available for trusting - I merely pointed out that they could be in 20 different hospitals.
For self tests I'd create an assessment involving users trying out the test and then completing a questionnaire to give me both qualitative feedback andvquantative (could call tgisva user ability index if comparing). Well that's what I did in the seven clinical trials I ran and published - you might have read them whilst you did the paperwork in regulatory.
wyndrum - sorry I didn't answer your direct question. - I would hold still as I believe in the company and more importantly I trust my research and knowledge of this area. If the drop was accompanied by something material from the company then I would need to reconsider but simply failing a support level now given how played about with this stock has been - I would hold.
Whoops, the bed is wet again. More utter sh.t...
‘if AVCT do fail to deliver the product on time/before someone else, that that could cause the SP to halve or more’
You like factual posts do you? Back it up bed wetter... When is on time? Before who? Why would it cause the SP to halve or more?
wyndrum - news will always trump charts and TA no question. And the fundamentals as strong as they are require News as confirmation and trajectory. In the periods between major News however the charts give a very strong indication of where the share wanders - I think we both agree with that. So implying a drop in price is someway indicative of a change in the fundamentals is clearly nonsense. there is no news or event that changes (negatively) the fundamentals for this company to any extent at all in the last few weeks. The announcements yesterday cited by some to try and imply a change are simply irrelevant in the context of this company and their product portfolio and the current market place.
I think you are unnecessarily agitating using non relevant and sometimes contrived "facts". As much as you think you are calling out the uber rampers (who to be fair I dislike too) your arguments do not stack up and are just niggly and troublesome.
I suspect we'll continue to disagree but as you do at least interact politely I suggest we just accept we disagree and leave it there. Others can make their own minds up.
One of the reason charts are used is that you ignore the fundamentals. So which is it?
If you want to play charts that's fine but it continually fails to break 150p it created a double top fell from their and then all the way back almost to the support as you say around 123p. That's fine but you bias (through fundamentals) is that the next update will be positive, because you don't talk about it falling below 123p. And just for the sake of this convo, what would you do if it did break 123p strong support? Would you sell, and if not why not?
I am not spreading fear (it certainly is not my intention).
Interesting thread to follow, but i'm curious €RorkesDrift, what are your thoughts on what are the most important factors in a clinical validation protocol. I understand much of what Ophidian is driving at but am doubting that you do. It would be interesting to understand your counter position